Lung Cancer Alliance | Strategic Alliance Partnership

The Lung Cancer Alliance has joined a growing list of patient advocacy organizations in supporting the American Cancer Society Cancer Action Network's advertising campaign urging the Trump administration not to limit access to lifesavings medications under Medicare.

The House of Representatives’ passage of a bipartisan amendment securing an additional $6 million to the Department of Defense Lung Cancer Research Program in the 2019 fiscal year budget brought praise from Lung Cancer Alliance.